Merck Global Health Innovation Fund — 2018 Investments

2 investments dated 2018 · listed companies and verified rows first · show all

Livongolivongo.com in 𝕏Apr 2018 · $105M

Livongo offers a chronic condition management program combining connected health-monitoring devices (blood glucose meters, blood pressure monitors, scales), certified health coaches, and clinical support to help members manage diabetes, hypertension, and weight, including GLP-1 medication access.

Digital HealthHealthtechWellness & FitnessMountain View, US

JOSEPH E. CAREY(Executive Officer)BRIAN VANDENBERG(Executive Officer)MARIO CHRISTOPHER(Executive Officer)

Board BETH SEIDENBERG(Board Director (Kleiner Perkins))in LEE SHAPIRO(Director)in HEMANT TANEJA(Director)in

Co-investors7wire Ventures Corewell Health Ventures General Catalyst Human Capital Kleiner Perkins Sapphire Ventures +7 more

Strata Oncologystrataoncology.com in 𝕏May 2018 · $26M

Strata Oncology develops precision oncology biomarkers and predictive diagnostic tools for cancer treatment, including treatment response scores for antibody-drug conjugates (ADCs) and an Immunotherapy Response Score for anti-PD-1/PD-L1 therapies.

AI & Machine LearningBiotechDigital HealthMedical DevicesAnn Arbor, US

Daniel Rhodes(Executive Officer, Director)Matthew Martin(Executive Officer)Jeffrey Williams(Executive Officer, Director)

Board Christopher O'Donnell(Director)inDavid Rubin(Director)in James Pavlik(Director)in

Co-investorsArboretum Ventures Pfizer Venture Investments Baird Capital Deerfield Management Company Pfizer Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.